
Global Maternal Pertussis Vaccine for Newborn Protection Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Maternal Pertussis Vaccine for Newborn Protection market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Maternal Pertussis Vaccine for Newborn Protection include Zhifei Biological, Walvax, Minhai Biological, GlaxoSmithKline, Sanofi Pasteur and Intravacc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Maternal Pertussis Vaccine for Newborn Protection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Maternal Pertussis Vaccine for Newborn Protection.
The Maternal Pertussis Vaccine for Newborn Protection market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Maternal Pertussis Vaccine for Newborn Protection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Maternal Pertussis Vaccine for Newborn Protection Segment by Company
Zhifei Biological
Walvax
Minhai Biological
GlaxoSmithKline
Sanofi Pasteur
Intravacc
Maternal Pertussis Vaccine for Newborn Protection Segment by Type
Whole-cell Pertussis Vaccine
Acellular Pertussis Vaccine
Maternal Pertussis Vaccine for Newborn Protection Segment by Application
Hospital
Centers for Disease Control and Prevention
Others
Maternal Pertussis Vaccine for Newborn Protection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Pertussis Vaccine for Newborn Protection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Maternal Pertussis Vaccine for Newborn Protection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Pertussis Vaccine for Newborn Protection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Maternal Pertussis Vaccine for Newborn Protection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Maternal Pertussis Vaccine for Newborn Protection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Maternal Pertussis Vaccine for Newborn Protection market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Maternal Pertussis Vaccine for Newborn Protection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global manufacturers of Maternal Pertussis Vaccine for Newborn Protection include Zhifei Biological, Walvax, Minhai Biological, GlaxoSmithKline, Sanofi Pasteur and Intravacc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Maternal Pertussis Vaccine for Newborn Protection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Maternal Pertussis Vaccine for Newborn Protection.
The Maternal Pertussis Vaccine for Newborn Protection market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Maternal Pertussis Vaccine for Newborn Protection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Maternal Pertussis Vaccine for Newborn Protection Segment by Company
Zhifei Biological
Walvax
Minhai Biological
GlaxoSmithKline
Sanofi Pasteur
Intravacc
Maternal Pertussis Vaccine for Newborn Protection Segment by Type
Whole-cell Pertussis Vaccine
Acellular Pertussis Vaccine
Maternal Pertussis Vaccine for Newborn Protection Segment by Application
Hospital
Centers for Disease Control and Prevention
Others
Maternal Pertussis Vaccine for Newborn Protection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Maternal Pertussis Vaccine for Newborn Protection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Maternal Pertussis Vaccine for Newborn Protection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Maternal Pertussis Vaccine for Newborn Protection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Maternal Pertussis Vaccine for Newborn Protection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Maternal Pertussis Vaccine for Newborn Protection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
94 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Estimates and Forecasts (2020-2031)
- 1.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales Estimates and Forecasts (2020-2031)
- 1.3 Maternal Pertussis Vaccine for Newborn Protection Market by Type
- 1.3.1 Whole-cell Pertussis Vaccine
- 1.3.2 Acellular Pertussis Vaccine
- 1.4 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Type
- 1.4.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Overview by Type (2020-2031)
- 1.4.2 Global Maternal Pertussis Vaccine for Newborn Protection Historic Market Size Review by Type (2020-2025)
- 1.4.3 Global Maternal Pertussis Vaccine for Newborn Protection Forecasted Market Size by Type (2026-2031)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Type (2020-2025)
- 1.5.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Type (2020-2025)
- 1.5.3 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Type (2020-2025)
- 1.5.4 South America Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Type (2020-2025)
- 1.5.5 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Type (2020-2025)
- 2 Global Market Dynamics
- 2.1 Maternal Pertussis Vaccine for Newborn Protection Industry Trends
- 2.2 Maternal Pertussis Vaccine for Newborn Protection Industry Drivers
- 2.3 Maternal Pertussis Vaccine for Newborn Protection Industry Opportunities and Challenges
- 2.4 Maternal Pertussis Vaccine for Newborn Protection Industry Restraints
- 3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Maternal Pertussis Vaccine for Newborn Protection Revenue (2020-2025)
- 3.2 Global Top Players by Maternal Pertussis Vaccine for Newborn Protection Sales (2020-2025)
- 3.3 Global Top Players by Maternal Pertussis Vaccine for Newborn Protection Price (2020-2025)
- 3.4 Global Maternal Pertussis Vaccine for Newborn Protection Industry Company Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Maternal Pertussis Vaccine for Newborn Protection Major Company Production Sites & Headquarters
- 3.6 Global Maternal Pertussis Vaccine for Newborn Protection Company, Product Type & Application
- 3.7 Global Maternal Pertussis Vaccine for Newborn Protection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Maternal Pertussis Vaccine for Newborn Protection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Maternal Pertussis Vaccine for Newborn Protection Players Market Share by Revenue in 2024
- 3.8.3 2023 Maternal Pertussis Vaccine for Newborn Protection Tier 1, Tier 2, and Tier 3
- 4 Maternal Pertussis Vaccine for Newborn Protection Regional Status and Outlook
- 4.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size and CAGR by Region: 2020 VS 2024 VS 2031
- 4.2 Global Maternal Pertussis Vaccine for Newborn Protection Historic Market Size by Region
- 4.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales in Volume by Region (2020-2025)
- 4.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales in Value by Region (2020-2025)
- 4.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales (Volume & Value), Price and Gross Margin (2020-2025)
- 4.3 Global Maternal Pertussis Vaccine for Newborn Protection Forecasted Market Size by Region
- 4.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales in Volume by Region (2026-2031)
- 4.3.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales in Value by Region (2026-2031)
- 4.3.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales (Volume & Value), Price and Gross Margin (2026-2031)
- 5 Maternal Pertussis Vaccine for Newborn Protection by Application
- 5.1 Maternal Pertussis Vaccine for Newborn Protection Market by Application
- 5.1.1 Hospital
- 5.1.2 Centers for Disease Control and Prevention
- 5.1.3 Others
- 5.2 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Application
- 5.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Overview by Application (2020-2031)
- 5.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Historic Market Size Review by Application (2020-2025)
- 5.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Forecasted Market Size by Application (2026-2031)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Application (2020-2025)
- 5.3.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Application (2020-2025)
- 5.3.3 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Application (2020-2025)
- 5.3.4 South America Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Application (2020-2025)
- 5.3.5 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Breakdown by Application (2020-2025)
- 6 Company Profiles
- 6.1 Zhifei Biological
- 6.1.1 Zhifei Biological Comapny Information
- 6.1.2 Zhifei Biological Business Overview
- 6.1.3 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
- 6.1.4 Zhifei Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 6.1.5 Zhifei Biological Recent Developments
- 6.2 Walvax
- 6.2.1 Walvax Comapny Information
- 6.2.2 Walvax Business Overview
- 6.2.3 Walvax Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
- 6.2.4 Walvax Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 6.2.5 Walvax Recent Developments
- 6.3 Minhai Biological
- 6.3.1 Minhai Biological Comapny Information
- 6.3.2 Minhai Biological Business Overview
- 6.3.3 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
- 6.3.4 Minhai Biological Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 6.3.5 Minhai Biological Recent Developments
- 6.4 GlaxoSmithKline
- 6.4.1 GlaxoSmithKline Comapny Information
- 6.4.2 GlaxoSmithKline Business Overview
- 6.4.3 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
- 6.4.4 GlaxoSmithKline Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 6.4.5 GlaxoSmithKline Recent Developments
- 6.5 Sanofi Pasteur
- 6.5.1 Sanofi Pasteur Comapny Information
- 6.5.2 Sanofi Pasteur Business Overview
- 6.5.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
- 6.5.4 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 6.5.5 Sanofi Pasteur Recent Developments
- 6.6 Intravacc
- 6.6.1 Intravacc Comapny Information
- 6.6.2 Intravacc Business Overview
- 6.6.3 Intravacc Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue and Gross Margin (2020-2025)
- 6.6.4 Intravacc Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
- 6.6.5 Intravacc Recent Developments
- 7 North America by Country
- 7.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country
- 7.1.1 North America Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.1.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025)
- 7.1.3 North America Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2031)
- 7.2 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
- 7.2.1 North America Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2.2 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2020-2025)
- 7.2.3 North America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2031)
- 8 Europe by Country
- 8.1 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country
- 8.1.1 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.1.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025)
- 8.1.3 Europe Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2031)
- 8.2 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
- 8.2.1 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2.2 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2020-2025)
- 8.2.3 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific by Country
- 9.1 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Country
- 9.1.1 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.1.2 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025)
- 9.1.3 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2031)
- 9.2 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
- 9.2.1 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2.2 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2020-2025)
- 9.2.3 Asia-Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2031)
- 10 South America by Country
- 10.1 South America Maternal Pertussis Vaccine for Newborn Protection Sales by Country
- 10.1.1 South America Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.1.2 South America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025)
- 10.1.3 South America Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2031)
- 10.2 South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
- 10.2.1 South America Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2.2 South America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2020-2025)
- 10.2.3 South America Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2031)
- 11 Middle East and Africa by Country
- 11.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country
- 11.1.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.1.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2020-2025)
- 11.1.3 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Forecast by Country (2026-2031)
- 11.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country
- 11.2.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country (2020-2025)
- 11.2.3 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size Forecast by Country (2026-2031)
- 12 Value Chain and Sales Channels Analysis
- 12.1 Maternal Pertussis Vaccine for Newborn Protection Value Chain Analysis
- 12.1.1 Maternal Pertussis Vaccine for Newborn Protection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process
- 12.2 Maternal Pertussis Vaccine for Newborn Protection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Maternal Pertussis Vaccine for Newborn Protection Distributors
- 12.2.3 Maternal Pertussis Vaccine for Newborn Protection Customers
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.